By G HossainPosted on August 7, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Analysts expect Replimune’s newly approved Tudriqev to reach $1.3 billion in peak sales in 2035. Replimune to ride wave of physician support to launch advanced melanoma therapy Post navigation 2026 Q2 Job Market Report: Job postings keep rising as fewer companies cut employeesEnsoma cuts jobs, narrows focus to lead asset
